nach oben

Journal of Endocrinological Investigation

Erschienen in:

01.10.2018 | Original Article

Association between vitamin D deficiency and risk of thyroid cancer: a case–control study and a meta-analysis

verfasst von: M.-J. Hu, Q. Zhang, L. Liang, S.-Y. Wang, X.-C. Zheng, M.-M. Zhou, Y.-W. Yang, Q. Zhong, F. Huang

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Although vitamin D is reportedly associated with various cancers, the association between vitamin D and thyroid cancer is indefinite. We aimed to investigate whether this association applies to thyroid cancer (TC).

Methods

A total of 276 Chinese Han people were recruited in a current matched case–control study. Multivariable conditional logistic regression was computed to estimate the association between plasma 25(OH)D and papillary thyroid cancer (PTC). In addition, we searched relevant studies in PubMed and Web of Science databases before December 2017 to conduct a meta-analysis.

Results

In our case–control study, plasma 25(OH)D concentration was inversely associated with PTC risk (highest tertile vs lowest tertile: adjusted OR = 0.25; 95% CI 0.10, 0.61; P_trend = 0.003). This association was independent of body mass index and physical activity (all adjusted P_interaction > 0.05). A total of 11 studies were included in the meta-analysis, among which ten studies have been published and one was our case–control study. Compared with 25(OH)D non-deficient group, the pooled OR of TC was 1.42 (95% CI 1.17, 1.73) in the deficient group. Similarly, blood 25(OH)D levels in patients with TC were tend to be lower than those in the controls (SMD = − 0.20, 95% CI − 0.36, − 0.03).

Conclusions

A high level of circulating 25(OH)D was associated with a decreased TC risk. This association has important significance in public health and should, therefore, be further studied.

Nur mit Berechtigung zugänglich

Malandrino P, Pellegriti G, Attard M, Violi MA, Giordano C, Sciacca L, Regalbuto C, Squatrito S, Vigneri R (2013) Papillary thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries. J Clin Endocrinol Metabol 98(4):1427–1434. https://doi.org/10.1210/jc.2012-3728 CrossRef

Vaccarella S, Dal Maso L, Laversanne M, Bray F, Plummer M, Franceschi S (2015) The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries. Thyroid 25(10):1127–1136. https://doi.org/10.1089/thy.2015.0116 CrossRefPubMed

Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA 317(13):1338–1348. https://doi.org/10.1001/jama.2017.2719 CrossRefPubMedPubMedCentral

Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66(2):115–132. https://doi.org/10.3322/caac.21338 CrossRefPubMed

Sinnott B, Ron E, Schneider AB (2010) Exposing the thyroid to radiation: a review of its current extent, risks, and implications. Endocr Rev 31(5):756–773. https://doi.org/10.1210/er.2010-0003 CrossRefPubMedPubMedCentral

Xhaard C, de Vathaire F, Clero E, Maillard S, Ren Y, Borson-Chazot F, Sassolas G, Schvartz C, Colonna M, Lacour B, Danzon A, Velten M, Marrer E, Bailly L, Barjoan EM, Schlumberger M, Orgiazzi J, Adjadj E, Rubino C (2015) Anthropometric risk factors for differentiated thyroid cancer in young men and women from eastern france: a case–control Study. Am J Epidemiol 182(3):202–214. https://doi.org/10.1093/aje/kwv048 CrossRefPubMed

Hwang Y, Lee KE, Park YJ, Kim SJ, Kwon H, Park DJ, Cho B, Choi HC, Kang D, Park SK (2016) Annual average changes in adult obesity as a risk factor for papillary thyroid cancer: a large-scale case–control Study. Medicine 95(9):e2893. https://doi.org/10.1097/MD.0000000000002893 CrossRefPubMedPubMedCentral

Xhaard C, Rubino C, Clero E, Maillard S, Ren Y, Borson-Chazot F, Sassolas G, Schvartz C, Colonna M, Lacour B, Danzon A, Velten M, Buemi A, Bailly L, Marine Barjoan E, Schlumberger M, Orgiazzi J, Adjadj E, de Vathaire F (2014) Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in young women in France: a population-based case-control study. Am J Epidemiol 180(10):1007–1017. https://doi.org/10.1093/aje/kwu220 CrossRefPubMed

Zamora-Ros R, Castaneda J, Rinaldi S, Cayssials V, Slimani N, Weiderpass E, Tsilidis KK, Boutron-Ruault MC, Overvad K, Eriksen AK, Tjonneland A, Kuhn T, Katzke V, Boeing H, Trichopoulou A, La Vecchia C, Kotanidou A, Palli D, Grioni S, Mattiello A, Tumino R, Sciannameo V, Lund E, Merino S, Salamanca- Fernandez E, Amiano P, Huerta JM, Barricarte A, Ericson U, Almquist M, Hennings J, Sandstrom M, Bueno-de-Mesquita HB, Peeters PH, Khaw KT, Wareham NJ, Schmidt JA, Cross AJ, Riboli E, Scalbert A, Romieu I, Agudo A, Franceschi S (2017) consumption of fish is not associated with risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition (epic) Study. J Nutr 147(7):1366–1373. https://doi.org/10.3945/jn.117.247874 CrossRefPubMed

10.

Sen A, Tsilidis KK, Allen NE, Rinaldi S, Appleby PN, Almquist M, Schmidt JA, Dahm CC, Overvad K, Tjonneland A, Rostgaard-Hansen AL, Clavel-Chapelon F, Baglietto L, Boutron-Ruault MC, Kuhn T, Katze VA, Boeing H, Trichopoulou A, Tsironis C, Lagiou P, Palli D, Pala V, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita HA, Peeters PH, Hjartaker A, Lund E, Weiderpass E, Quiros JR, Agudo A, Sanchez MJ, Arriola L, Gavrila D, Gurrea AB, Tosovic A, Hennings J, Sandstrom M, Romieu I, Ferrari P, Zamora-Ros R, Khaw KT, Wareham NJ, Riboli E, Gunter M, Franceschi S (2015) Baseline and lifetime alcohol consumption and risk of differentiated thyroid carcinoma in the EPIC study. Br J Cancer 113(5):840–847. https://doi.org/10.1038/bjc.2015.280 CrossRefPubMedPubMedCentral

11.

Zamora-Ros R, Rinaldi S, Tsilidis KK, Weiderpass E, Boutron-Ruault MC, Rostgaard-Hansen AL, Tjonneland A, Clavel-Chapelon F, Mesrine S, Katzke VA, Kuhn T, Forster J, Boeing H, Trichopoulou A, Lagiou P, Klinaki E, Masala G, Sieri S, Ricceri F, Tumino R, Mattiello A, Peeters PH, Bueno-de-Mesquita HB, Engeset D, Skeie G, Arguelles M, Agudo A, Sanchez MJ, Chirlaque MD, Barricarte A, Chamosa S, Almquist M, Tosovic A, Hennings J, Sandstrom M, Schmidt JA, Khaw KT, Wareham NJ, Cross AJ, Slimani N, Byrnes G, Romieu I, Riboli E, Franceschi S (2016) Energy and macronutrient intake and risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer 138(1):65–73. https://doi.org/10.1002/ijc.29693 CrossRefPubMed

12.

Kim D (2017) The role of vitamin D in thyroid diseases. Int J Mol Sci. https://doi.org/10.3390/ijms18091949 CrossRefPubMedPubMedCentral

13.

Muscogiuri G, Tirabassi G, Bizzaro G, Orio F, Paschou SA, Vryonidou A, Balercia G, Shoenfeld Y, Colao A (2015) Vitamin D and thyroid disease: to D or not to D? Eur J Clin Nutr 69(3):291–296. https://doi.org/10.1038/ejcn.2014.265 CrossRefPubMed

14.

Yu J, Mai W, Cui Y, Kong L (2016) Key genes and pathways predicted in papillary thyroid carcinoma based on bioinformatics analysis. J Endocrinol Invest 39(11):1285–1293. https://doi.org/10.1007/s40618-016-0491-z CrossRefPubMed

15.

Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281. https://doi.org/10.1056/NEJMra070553 CrossRefPubMed

16.

Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ (2014) The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 14(5):342–357. https://doi.org/10.1038/nrc3691 CrossRefPubMed

17.

Dackiw AP, Ezzat S, Huang P, Liu W, Asa SL (2004) Vitamin D3 administration induces nuclear p27 accumulation, restores differentiation, and reduces tumor burden in a mouse model of metastatic follicular thyroid cancer. Endocrinology 145(12):5840–5846. https://doi.org/10.1210/en.2004-0785 CrossRefPubMed

18.

Clinckspoor I, Verlinden L, Overbergh L, Korch C, Bouillon R, Mathieu C, Verstuyf A, Decallonne B (2011) 1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer. J Steroid Biochem Mol Biol 124(1–2):1–9. https://doi.org/10.1016/j.jsbmb.2010.12.008 CrossRefPubMed

19.

Fleet JC, DeSmet M, Johnson R, Li Y (2012) Vitamin D and cancer: a review of molecular mechanisms. Biochem J 441(1):61–76. https://doi.org/10.1042/BJ20110744 CrossRefPubMed

20.

Somjen D, Grafi-Cohen M, Posner GH, Sharon O, Kraiem Z, Stern N (2013) Vitamin D less-calcemic analog modulates the expression of estrogen receptors, vitamin D receptor and 1alpha-hydroxylase 25-hydroxy vitamin D in human thyroid cancer cell lines. J Steroid Biochem Mol Biol 136:80–82. https://doi.org/10.1016/j.jsbmb.2012.09.015 CrossRefPubMed

21.

Wang F, Wang Y, Wang L, Wang X, Sun C, Xing M, Zhao W (2014) Strong association of high urinary iodine with thyroid nodule and papillary thyroid cancer. Tumour Biol 35(11):11375–11379. https://doi.org/10.1007/s13277-014-2397-8 CrossRefPubMed

22.

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine S (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metabol 96(7):1911–1930. https://doi.org/10.1210/jc.2011-0385 CrossRef

23.

Stang A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605. https://doi.org/10.1007/s10654-010-9491-z CrossRefPubMed

24.

Hu J, Dong Y, Chen X, Liu Y, Ma D, Liu X, Zheng R, Mao X, Chen T, He W (2015) Prevalence of suicide attempts among Chinese adolescents: a meta-analysis of cross-sectional studies. Compr Psychiatry 61:78–89. https://doi.org/10.1016/j.comppsych.2015.05.001 CrossRefPubMed

25.

Belardi V, Fiore E, Giustarini E, Muller I, Sabatini S, Rosellini V, Seregni E, Agresti R, Marcocci C, Vitti P, Giani C (2013) Is the risk of primary hyperparathyroidism increased in patients with untreated breast cancer? J Endocrinol Invest 36(5):321–325. https://doi.org/10.3275/8580 CrossRefPubMed

26.

Choi YM, Kim WG, Kim TY, Bae SJ, Kim HK, Jang EK, Jeon MJ, Han JM, Shong YK, Kim WB (2017) Serum vitamin D3 levels are not associated with thyroid cancer prevalence in euthyroid subjects without autoimmune thyroid disease. Korean J Intern Med 32(1):102–108. https://doi.org/10.3904/kjim.2015.090 CrossRefPubMed

27.

Roskies M, Dolev Y, Caglar D, Hier MP, Mlynarek A, Majdan A, Payne RJ (2012) Vitamin D deficiency as a potentially modifiable risk factor for thyroid cancer. J Otolaryngol Head Neck Surg = Le Journal d’oto-rhino-laryngologie et de chirurgie cervico-faciale 41(3):160–163

28.

Laney N, Meza J, Lyden E, Erickson J, Treude K, Goldner W (2010) The prevalence of vitamin D deficiency is similar between thyroid nodule and thyroid cancer patients. Int J Endocrinol 2010:805716. https://doi.org/10.1155/2010/805716 CrossRefPubMed

29.

Penna-Martinez M, Ramos-Lopez E, Stern J, Hinsch N, Hansmann ML, Selkinski I, Grunwald F, Vorlander C, Wahl RA, Bechstein WO, Zeuzem S, Holzer K, Badenhoop K (2009) Vitamin D receptor polymorphisms in differentiated thyroid carcinoma. Thyroid 19(6):623–628. https://doi.org/10.1089/thy.2008.0388 CrossRefPubMed

30.

Jonklaas J, Danielsen M, Wang H (2013) A pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancer. Thyroid 23(9):1079–1086. https://doi.org/10.1089/thy.2012.0548 CrossRefPubMedPubMedCentral

31.

Danilovic DL, Ferraz-de-Souza B, Fabri AW, Santana NO, Kulcsar MA, Cernea CR, Marui S, Hoff AO (2016) 25-Hydroxyvitamin D and TSH as risk factors or prognostic markers in thyroid carcinoma. PLoS One 11(10):e0164550. https://doi.org/10.1371/journal.pone.0164550 CrossRefPubMedPubMedCentral

32.

Sahin M, Ucan B, Ginis Z, Topaloglu O, Gungunes A, Bozkurt NC, Arslan MS, Unsal IO, Akkaymak ET, Demirci T, Karakose M, Caliskan M, Cakal E, Ozbek M, Delibasi T (2013) Vitamin D3 levels and insulin resistance in papillary thyroid cancer patients. Med Oncol 30(2):589. https://doi.org/10.1007/s12032-013-0589-5 CrossRefPubMed

33.

Penna-Martinez M, Ramos-Lopez E, Stern J, Kahles H, Hinsch N, Hansmann ML, Selkinski I, Grunwald F, Vorlander C, Bechstein WO, Zeuzem S, Holzer K, Badenhoop K (2012) Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma. Thyroid 22(7):709–716. https://doi.org/10.1089/thy.2011.0330 CrossRefPubMedPubMedCentral

34.

Emami A, Nazem MR, Shekarriz R, Hedayati M (2017) Micronutrient status (calcium, zinc, vitamins D and E) in patients with medullary thyroid carcinoma: a cross-sectional study. Nutrition 41:86–89. https://doi.org/10.1016/j.nut.2017.04.004 CrossRefPubMed

35.

Song Q, Wang B, Wang S, He Q, Zhang YM, Chen WH (2016) Significance of serum phosphorus, and vitamin D in papillary thyroid cancer patients in the eastern coastal China. Int J Clin Exp Pathol 9:3858

36.

Zhao H, Li H, Huang T (2017) High urinary iodine, thyroid autoantibodies, and thyroid-stimulating hormone for papillary thyroid cancer risk. Biol Trace Elem Res. https://doi.org/10.1007/s12011-017-1209-6 CrossRefPubMed

37.

Siegel RL, Miller KD, Jemal A (2017) Cancer Statistics, 2017. CA Cancer J Clin 67(1):7–30. https://doi.org/10.3322/caac.21387 CrossRefPubMed

38.

Krishnan AV, Swami S, Feldman D (2010) Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling. J Steroid Biochem Mol Biol 121(1–2):343–348. https://doi.org/10.1016/j.jsbmb.2010.02.009 CrossRefPubMed

39.

Park S, Oh CM, Cho H, Lee JY, Jung KW, Jun JK, Won YJ, Kong HJ, Choi KS, Lee YJ, Lee JS (2016) Association between screening and the thyroid cancer “epidemic” in South Korea: evidence from a nationwide study. BMJ 355:i5745. https://doi.org/10.1136/bmj.i5745 CrossRefPubMedPubMedCentral

40.

Wang J, Lv S, Chen G, Gao C, He J, Zhong H, Xu Y (2015) Meta-analysis of the association between vitamin D and autoimmune thyroid disease. Nutrients 7(4):2485–2498. https://doi.org/10.3390/nu7042485 CrossRefPubMedPubMedCentral

41.

Kivity S, Agmon-Levin N, Zisappl M, Shapira Y, Nagy EV, Danko K, Szekanecz Z, Langevitz P, Shoenfeld Y (2011) Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol 8(3):243–247. https://doi.org/10.1038/cmi.2010.73 CrossRefPubMedPubMedCentral

42.

Castoro C, Le Moli R, Arpi ML, Tavarelli M, Sapuppo G, Frittitta L, Squatrito S, Pellegriti G (2016) Association of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institution. J Endocrinol Invest 39(7):779–784. https://doi.org/10.1007/s40618-016-0445-5 CrossRefPubMed

43.

Zhang L, Li H, Ji QH, Zhu YX, Wang ZY, Wang Y, Huang CP, Shen Q, Li DS, Wu Y (2012) The clinical features of papillary thyroid cancer in Hashimoto’s thyroiditis patients from an area with a high prevalence of Hashimoto’s disease. BMC Cancer 12:610. https://doi.org/10.1186/1471-2407-12-610 CrossRefPubMedPubMedCentral

44.

Zheng J, Li C, Lu W, Wang C, Ai Z (2016) Quantitative assessment of preoperative serum thyrotropin level and thyroid cancer. Oncotarget 7(23):34918–34929. https://doi.org/10.18632/oncotarget.9201 CrossRefPubMedPubMedCentral

45.

Rinaldi S, Plummer M, Biessy C, Tsilidis KK, Ostergaard JN, Overvad K, Tjonneland A, Halkjaer J, Boutron-Ruault MC, Clavel-Chapelon F, Dossus L, Kaaks R, Lukanova A, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Agnoli C, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Lund E, Quiros JR, Agudo A, Molina E, Larranaga N, Navarro C, Ardanaz E, Manjer J, Almquist M, Sandstrom M, Hennings J, Khaw KT, Schmidt J, Travis RC, Byrnes G, Scalbert A, Romieu I, Gunter M, Riboli E, Franceschi S (2014) Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. J Natl Cancer Inst 106(6):dju97. https://doi.org/10.1093/jnci/dju097 CrossRef

46.

Bizzaro G, Shoenfeld Y (2015) Vitamin D and autoimmune thyroid diseases: facts and unresolved questions. Immunol Res 61(1–2):46–52. https://doi.org/10.1007/s12026-014-8579-z CrossRefPubMed

47.

Kim JR, Kim BH, Kim SM, Oh MY, Kim WJ, Jeon YK, Kim SS, Lee BJ, Kim YK, Kim IJ (2014) Low serum 25 hydroxyvitamin D is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer. Thyroid 24(11):1618–1624. https://doi.org/10.1089/thy.2014.0090 CrossRefPubMed

48.

Yavropoulou MP, Panagiotou G, Topouridou K, Karayannopoulou G, Koletsa T, Zarampoukas T, Goropoulos A, Chatzaki E, Yovos JG, Pazaitou-Panayiotou K (2017) Vitamin D receptor and progesterone receptor protein and gene expression in papillary thyroid carcinomas: associations with histological features. J Endocrinol Invest 40(12):1327–1335. https://doi.org/10.1007/s40618-017-0700-4 CrossRefPubMed

49.

Palacios C, Gonzalez L (2014) Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol 144 Pt A:138–145. https://doi.org/10.1016/j.jsbmb.2013.11.003 CrossRefPubMed

50.

Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA, Pierroz DD, Weber P, Hoffmann K (2014) A systematic review of vitamin D status in populations worldwide. Br J Nutr 111(1):23–45. https://doi.org/10.1017/S0007114513001840 CrossRefPubMed

Titel: Association between vitamin D deficiency and risk of thyroid cancer: a case–control study and a meta-analysis
verfasst von: M.-J. Hu
Q. Zhang
L. Liang
S.-Y. Wang
X.-C. Zheng
M.-M. Zhou
Y.-W. Yang
Q. Zhong
F. Huang
Publikationsdatum: 01.10.2018
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 10/2018
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-018-0853-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Association between vitamin D deficiency and risk of thyroid cancer: a case–control study and a meta-analysis

Abstract

Purpose

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2018

Insulin sensitivity and secretion and adipokine profile in patients with Cushing’s disease treated with pasireotide

Efficacy and safety of long-term management of patients with chronic post-surgical hypoparathyroidism

The psychometric evaluation of the quality of life in short stature youth (QoLISSY) instrument for German children born small for gestational age

Daniel Lambert, a protagonist of real life with monstrous obesity in eighteenth century in England

Association between systemic leptin and neurotensin concentration in adult individuals with and without type 2 diabetes mellitus

Identification of key genes of papillary thyroid cancer using integrated bioinformatics analysis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin